Vazyme Biotech develops biological reagents, in vitro diagnostic reagents and antibody drugs from its base in Nanjing, China.
Vazyme Biotech Co.,Ltd. was established in 2012 in Nanjing, China, and works on biological reagents, in vitro diagnostic reagents and antibody drugs. Its catalog includes more than 500 biological reagents, such as PCR and qPCR series used in research, sequencing and vaccine development, plus eight series of in vitro diagnostic reagents. The company has more than 400 R&D staff and, as of June 2021, held 50 patents and 67 medical device registration certificates. It plans to build an R&D base and expand its marketing network.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in